| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Abivax SaABVX | $133.26 | Strong Buy | $158.00 | +18.57% | a day ago | |
Analyst RankingTop 8% #383 out of 5312 analysts Average Return+50.07% Win Rate51%18 out of 35 Risk vs RewardPoor Good Analyst ColorJefferies's Faisal Khurshid upgraded their rating on Abivax SA (NASDAQ: ABVX) from Hold to Strong Buy on 2026/07/01. The analyst also raised their price target by 46.3% from $108 to $158. Upgrading the stock and raising their price target on Abivax SA, Khurshid posited that the company's ABTECT part two update "appropriately addressed the key overhang facing the stock." The analyst detailed that, compared to the the part one update, management "did a nice job addressing investor concerns" when they presented the safety data, and argued that the efficacy profile strengthens with each additional piece of data. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||